Researcher Carolyn Rodriguez explores hallucinogen as potential #OCD treatment: https://t.co/nNcKd0jtWO pic.twitter.com/Ll5q0kDQDC
— Stanford Medicine (@StanfordMed) May 24, 2017
Ketamine study for OCD
Reply
Researcher Carolyn Rodriguez explores hallucinogen as potential #OCD treatment: https://t.co/nNcKd0jtWO pic.twitter.com/Ll5q0kDQDC
— Stanford Medicine (@StanfordMed) May 24, 2017